Vesalius Cardiovascular Announces the Completion of a Successful Chronic Animal Study
VANCOUVER, British Columbia, January 21, 2020 (Newswire.com) Vesalius Cardiovascular Inc. (VCI), a pre-clinical stage medical device company developing novel percutaneous therapies for the treatment of mitral regurgitation, today announced the successful completion of their first 30-day chronic animal study using their mitral valve repair device. The predetermined endpoints of the study were the absence of […]
Vesalius team is attending TCT 2019 in San Francisco
September 25-29, 2019 – Moscone Convention Center, San Francisco Vesalius team is attending TCT 2019 in San Francisco. This very specialized conference is the ideal occasion to learn more about the latest therapies in interventional cardiology and connect with corporations active in this field.
Vesalius wins top prize of $300,000 at the 2019 VGH and UBC Hospital Foundation Innovators’ Challenge
May 9, 2019 – VGH and UBC Hospital Foundation Innovators’ Challenge, Vancouver The VGH and UBC Hospital Foundation Innovators’ Challenge looks for three local medical teams involved in groundbreaking research and development to pitch their innovations to the Accelerator Panel. Vesalius was selected as one of three members of the health and technology industry, to […]
Vesalius is featured in the Life Sciences Bristish Columbia (LSBC) Annual Magazine 2019
February 20, 2019 – LSBC, Vancouver As the premier marketing piece for the BC life science ecosystem, LifeSciences BC publishes an annual magazine that identifies the innovation, pace and significant accomplishments of the life sciences sector in the last year. The 2019 theme for the magazine is Transformative Medicine: Targeted Insights – Advancing Discoveries. On […]
Vesalius Places 2nd in the “International Company” Category at the 2018 PitchfestNW in Portland
April 6, 2018 – TechfestNW, Portland TechfestNW annually hosts PitchfestNW, an international startup competition that recognizes the work of innovative companies. Vesalius was preselected to attend the event and pitch to global venture capitalists. On April 6th, the selection committee chose Vesalius as one of the top five startups to present to the entire conference […]
Vesalius Successful at Cascadia Venture Forum Vancouver
October 12, 2017 – VentureLabs, Vancouver. Vesalius Cardiovascular finishes in first place at the Vancouver Cascadia Venture Forum, from a field of 6 startup ventures in the Seed category, as voted by the audience of angels, VCs, entrepreneurs, and business mentors. Vesalius will now proceed to the Cascadia Summit Competition to be held in Seattle […]